Experimental BPA Exposure and Glucose-Stimulated Insulin Response in Adult Men and Women

@article{Stahlhut2018ExperimentalBE,
  title={Experimental BPA Exposure and Glucose-Stimulated Insulin Response in Adult Men and Women},
  author={Richard W. Stahlhut and John Peterson Myers and Julia A. Taylor and Angel Nadal and Jonathan A Dyer and Frederick S vom Saal},
  journal={Journal of the Endocrine Society},
  year={2018},
  volume={2},
  pages={1173 - 1187}
}
Abstract Context Human cross-sectional and animal studies have shown an association of the chemical bisphenol A (BPA) with insulin resistance, type 2 diabetes, and other metabolic diseases, but no human experimental study has investigated whether BPA alters insulin/C-peptide secretion. Design Men and postmenopausal women (without diabetes) were orally administered either the vehicle or a BPA dose of 50 µg/kg body weight, which has been predicted by US regulators (Food and Drug Administration… Expand
Rationale and design of a randomized controlled trial examining oral administration of bisphenol A on hepatic glucose production and skeletal muscle insulin sensitivity in adults
TLDR
Results from this study will provide a framework for other studies in this area, and provide much needed experimental evidence using gold standard measures as to whether oral BPA administration over several days poses any risk of type 2 diabetes. Expand
Pilot Study on the Effect of Orally Administered Bisphenol A on Glucose and Insulin Response in Nonobese Adults
TLDR
Orally administered BPA protocol appeared feasible and has immediate effects on glucose, insulin, and C-peptide concentrations. Expand
Developmental exposure to a very low dose of bisphenol A induces persistent islet insulin hypersecretion in Fischer 344 rat offspring.
TLDR
A BPA intake 8 times lower than the European Food Safety Authority's current tolerable daily intake (TDI) of 4 µg/kg BW/day of BPA delivered via drinking water during gestation and early development causes islet insulin hypersecretion in rat offspring up to one year after exposure. Expand
Prolonged bisphenol-A exposure decreases endocrine pancreatic proliferation in response to obesogenic diet in ovariectomized mice
TLDR
BPA consumption in OVX mice impaired the islet-cell hyperplasia response to the HFD, partly mediated by increased expression of ER-β and GPR30, which impaired the expression of major genes involved in islet -cell survival and functionality. Expand
Bisphenol A and Type 2 Diabetes Mellitus: A Review of Epidemiologic, Functional, and Early Life Factors
TLDR
Type 2 diabetes mellitus (T2DM) is characterised by insulin resistance and eventual pancreatic β-cell dysfunction, resulting in persistent high blood glucose levels, and BPA is a pervasive EDC, being the main constituent of polycarbonate plastics. Expand
Novel insights of elevated systemic levels of bisphenol-A (BPA) linked to poor glycemic control, accelerated cellular senescence and insulin resistance in patients with type 2 diabetes
TLDR
This study is the first data in the clinical diabetes setting to demonstrate an association of increased BPA levels with cellular senescence, proinflammation, poor glycemic control, insulin resistance, and shortened telomeres in patients with T2DM. Expand
Exposure to low doses of Dechlorane Plus promotes adipose tissue dysfunction and glucose intolerance in male mice.
TLDR
Exposure of mice to low, environmentally relevant doses of Dechlorane Plus (DP), promoted glucose intolerance in mice fed high fat diet independent of weight gain and had pronounced effects on the adipose tissue. Expand
Bisphenol A-induced metabolic disorders: From exposure to mechanism of action.
TLDR
The sources of BPA exposure to human being and the evidence from epidemiological studies linking DM with BPA Exposure are summarized and the potential molecular pathways for BPA-induced DM are highlighted. Expand
Exposure to Bisphenol a Substitutes and Gestational Diabetes Mellitus: A Prospective Cohort Study in China
TLDR
Evidence is provided that BPAF and BPS might be potential risk factors of GDM, which require to be studied further. Expand
Oestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells
TLDR
The data suggest that BPA modulates the expression and function of Na+ and K+ channels via ERβ in mouse pancreatic islets, and BPA alters beta cell electrical activity. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 49 REFERENCES
The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance
TLDR
The results in this article show that the widespread environmental contaminant bisphenol-A (BPA) imitates 17β-estradiol (E2) effects in vivo on blood glucose homeostasis through genomic and nongenomic pathways. Expand
Urinary Bisphenol A and Hypertension in a Multiethnic Sample of US Adults
TLDR
Urinary BPA levels are associated with hypertension, independent of traditional risk factors, and the association was consistently present in subgroup analyses by race/ethnicity, smoking status, BMI, and diabetes mellitus. Expand
Rapid Insulinotropic Action of Low Doses of Bisphenol-A on Mouse and Human Islets of Langerhans: Role of Estrogen Receptor β
TLDR
BPA behaves as a strong estrogen via nuclear ERβ and results obtained with BPA in mouse β-cells may be extrapolated to humans, suggesting that BPA should be considered as a risk factor for metabolic disorders in humans. Expand
Endocrine disruptors in the etiology of type 2 diabetes mellitus
TLDR
Evidence already exists to consider exposure to endocrine disrupting chemicals as a risk factor in the etiology of type 2 diabetes mellitus and other diseases related to insulin resistance, and more experimental work is necessary. Expand
Urinary Bisphenol A Concentration and Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women
Background— The endocrine-disrupting chemical bisphenol A (BPA) is widely used in food and beverage packaging. Higher urinary BPA concentrations were cross-sectionally associated with heart diseaseExpand
Urinary bisphenol A concentrations positively associated with glycated hemoglobin and other indicators of diabetes in Canadian men.
TLDR
Higher urinary BPA levels were associated with adverse glucose homeostasis in Canadian men, independent of major covariates and Prospective studies with longitudinal design are needed to further investigate the causality. Expand
Initial hyperinsulinemia and subsequent β-cell dysfunction is associated with elevated palmitate levels
TLDR
The rapid accentuated and delayed insulin secretory responses observed in obese children and adolescents, respectively, with high palmitate levels may reflect changes in islet secretory activity and integrity induced by extended exposure to the fatty acid. Expand
Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults.
TLDR
Higher BPA exposure, reflected in higher urinary concentrations of BPA, may be associated with avoidable morbidity in the community-dwelling adult population. Expand
Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents.
TLDR
Urinary BPA concentration was significantly associated with obesity in this cross-sectional study of children and adolescents and could not rule out the possibility that obese children ingest food with higher BPA content or have greater adipose stores of BPA. Expand
Oestrogens and insulin secretion
TLDR
Evidence from clinical trials suggesting that women on postmenopausal oestrogen hormone replacement therapy (HRT) have a reduced incidence of type 2 diabetes appears paradoxical, but the mechanism responsible for this benefit merits further investigation and might lead to new therapies. Expand
...
1
2
3
4
5
...